In brief, what’s happening at Penn—whether it’s across campus or around the world.
Penn Electric Racing is now the first American team to successfully run a four-wheel-drive vehicle at the student racecar competition Formula SAE Lincoln Electric. It earned REV5 third place overall at Lincoln, as well as the first place Cummins Inc. Applied Technology Award for the car’s battery design.
FULL STORY AT Penn Engineering Blog →
Theresa Larivee and Serena Dasani discuss their careers in academic medicine, how they combine financial and clinical expertise, and their approach to leadership.
FULL STORY AT Penn Medicine News →
Heading into his second year at the helm of the men's soccer program, James C. Gentle Head Coach Brian Gill has announced the upcoming slate of games for the 2019 edition of the Quakers.
FULL STORY AT Penn Athletics →
Rising sophomore Mayyi Mahama captured silver in the hammer throw for Team USA, highlighting a three-Quaker contingent at the U20 Pan American Championships in Costa Rica over the weekend.
FULL STORY AT Penn Athletics →
The women’s and men’s tennis teams were honored as All-Academic teams, and seven Quakers student-athletes—five men, two women—were honored as ITA All-Academic Scholar Athletes.
FULL STORY AT Penn Athletics →
In light of the death of former Supreme Court Associate Justice John Paul Stevens, Penn Law professor and former clerk Jean Galbraith reflects on his legacy.
FULL STORY AT Penn Carey Law →
As part of Pennsylvania’s commitment to close the achievement gaps and provide all students with high-quality teachers, the Woodrow Wilson National Fellowship Foundation announced the inaugural class of Pennsylvania Teaching Fellows.
FULL STORY AT Graduate School of Education →
Fran Dunphy, who spent 17 years as head coach of the men's basketball program and remains its winningest coach, was recently named as one of 15 sports greats to be inducted into the Philadelphia Sports Hall of Fame.
FULL STORY AT Penn Athletics →
Twenty one senior health care leaders were chosen to join the Aspen Institute Health Innovators Fellowship’s fifth class and the program’s network of health care entrepreneurs and innovators from across the United States.
FULL STORY AT Penn Nursing News →
Multiple trials have shown that by using these definitive treatment techniques on all visible tumor sites, patients can end up with better outcomes than what they would get with chemotherapy alone. The trial went one step further and added immunotherapy. In addition to the significant increase in overall average progression-free survival (PFS), the average PFS from the start of administering the drug pembrolizumab was 18.7 months.
FULL STORY AT Penn Medicine News →
